Display options
Share it on

Am J Blood Res. 2021 Apr 15;11(2):140-148. eCollection 2021.

Lower hair cortisol among patients with sickle cell disease may indicate decreased adrenal reserves.

American journal of blood research

Brittany M Hollister, Mihail Zilbermint, Caterina P Minniti, Ashley J Buscetta, Khadijah E Abdallah, Shuo You, Steven J Soldin, Jerrold S Meyer, Constantine A Stratakis, Vence L Bonham

Affiliations

  1. Social and Behavioral Research Branch, National Human Genome Research Institute, National Institutes of Health Bethesda, Maryland, USA.
  2. The University of Florida Genetics Institute Gainesville, Florida, USA.
  3. Section on Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health Bethesda, Maryland, USA.
  4. Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University School of Medicine Baltimore, Maryland, USA.
  5. Johns Hopkins Community Physicians at Suburban Hospital Bethesda, Maryland, USA.
  6. Division of Hematology, Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine New York, New York, USA.
  7. Department of Laboratory Medicine, Clinical Center, National Institutes of Health Bethesda, Maryland, USA.
  8. Department of Psychological and Brain Sciences, University of Massachusetts Amherst, Massachusetts, USA.

PMID: 34079627 PMCID: PMC8165714

Abstract

INTRODUCTION: Sickle cell disease (SCD) is a chronic illness that presents with a wide range of phenotypic variation. Stress may be a contributing factor to differences that are found in this population.

OBJECTIVES: Our objective is to determine the relationship between hair cortisol content (HCC), a biomarker of stress, and other clinical measures in individuals with SCD.

METHODS: We collected hair samples and other clinical measures from 73 subjects with SCD (mean age: 39 ± 12 years, 63% female).

RESULTS: HCC was lower among individuals who had greater than 30% hemoglobin S, compared with those who had less than 30% hemoglobin S (W=272.5, P=0.01). Lower HCC was also associated with report of not being on a chronic transfusion program (β=48.34, SE=14.09, P=0.001) and higher ferritin levels (β=-0.006, SE=0.002, P=0.02). Furthermore, HCC was significantly correlated with serum cortisol (r

CONCLUSION: Our findings suggest that individuals with higher hemoglobin S and ferritin, both markers of severe SCD, may have decreased cortisol levels. This is consistent with the relationship we observed between higher HCC among individuals who are on a chronic blood transfusion program, which typically increases quality of life. Our results suggest that hair cortisol may be an indicator in patients with SCD who could be at risk for developing adrenal insufficiency. We recommend that clinicians treating patients with SCD follow the Endocrine Society guidelines for testing for adrenal insufficiency and treat accordingly.

AJBR Copyright © 2021.

Keywords: Sickle cell disease; corticosteroids; sickle cell anemia; steroids

Conflict of interest statement

None.

References

  1. N Engl J Med. 2017 Jul 20;377(3):305 - PubMed
  2. Endocrine. 2017 Apr;56(1):164-174 - PubMed
  3. Biol Psychiatry. 2007 Sep 1;62(5):400-6 - PubMed
  4. Stress. 2016;19(1):45-52 - PubMed
  5. Ann N Y Acad Sci. 2006 Nov;1083:111-28 - PubMed
  6. Hematology Am Soc Hematol Educ Program. 2013;2013:447-56 - PubMed
  7. J Behav Med. 1999 Apr;22(2):115-26 - PubMed
  8. J Blood Med. 2016 Dec 13;7:283-289 - PubMed
  9. Psychoneuroendocrinology. 2017 Jun;80:36-38 - PubMed
  10. Biol Psychiatry. 2009 Nov 1;66(9):879-85 - PubMed
  11. Ann Endocrinol (Paris). 2017 Dec;78(6):490-494 - PubMed
  12. Endocrinology. 2012 Sep;153(9):4120-7 - PubMed
  13. J Natl Med Assoc. 2003 Jul;95(7):533-7 - PubMed
  14. Pan Afr Med J. 2018 Jan 12;29:30 - PubMed
  15. J Vis Exp. 2014 Jan 24;(83):e50882 - PubMed
  16. Int J Behav Med. 1998;5(3):185-203 - PubMed
  17. Br J Haematol. 2005 Jun;129(6):723-9 - PubMed
  18. Clin Med (Lond). 2017 Jun;17(3):258-262 - PubMed
  19. Endocr Connect. 2018 Dec;7(12):1354-1361 - PubMed
  20. Psychoneuroendocrinology. 2016 Oct;72:212-8 - PubMed
  21. J Clin Endocrinol Metab. 2008 May;93(5):1526-40 - PubMed
  22. Blood Cells Mol Dis. 2018 Sep;72:1-9 - PubMed
  23. Ann Epidemiol. 2015 Feb;25(2):90-5, 95.e1-2 - PubMed
  24. Forensic Sci Int. 2000 Jan 10;107(1-3):5-12 - PubMed
  25. Eur J Endocrinol. 2010 Mar;162(3):597-602 - PubMed
  26. Eur J Endocrinol. 2015 Oct;173(4):M33-8 - PubMed
  27. Am J Hematol. 1980;9(4):373-9 - PubMed
  28. J Intern Med. 2000 Feb;247(2):188-97 - PubMed
  29. BMC Psychiatry. 2014 Jul 21;14:207 - PubMed
  30. Ann N Y Acad Sci. 2017 Mar;1391(1):20-34 - PubMed
  31. Health Psychol Open. 2017 Mar 27;4(1):2055102917695176 - PubMed
  32. Stress Health. 2013 Oct;29(4):337-44 - PubMed
  33. Acta Haematol. 1988;79(1):44-5 - PubMed
  34. Clin Endocrinol (Oxf). 2013 Feb;78(2):271-7 - PubMed
  35. PLoS One. 2013 Nov 04;8(11):e77913 - PubMed
  36. Public Health Rep. 2019 Nov/Dec;134(6):599-607 - PubMed
  37. J Consult Clin Psychol. 1992 Jun;60(3):433-40 - PubMed
  38. Exp Clin Endocrinol Diabetes. 2013 Jan;121(1):32-6 - PubMed
  39. Psychoneuroendocrinology. 2012 May;37(5):589-601 - PubMed
  40. Int J Behav Med. 2005;12(3):171-9 - PubMed
  41. J Health Psychol. 2000 Jan;5(1):53-63 - PubMed
  42. J Clin Endocrinol Metab. 2016 Feb;101(2):364-89 - PubMed
  43. Expert Rev Endocrinol Metab. 2018 Sep;13(5):225-231 - PubMed

Publication Types